Follow The Filings

USNA Usana Health Sciences Inc.

Health Care, filed as USANA HEALTH SCIENCES INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.1%
  • $26M
  • 1 add

In 2026 Q2 Richard Pzena added to Usana Health Sciences.

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Richard Pzena, Pzena Investment Management). Not free-float ownership.

  1. Richard Pzena Add 0.08%

Who owns USNA

Sorted by value, long equity only, as of 2026 Q2.

History
Richard Pzena, Pzena Investment Management 0.08%, was 0.07% Add +8.7% 1,205,587 $26M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by USNA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All USNA insider trades
  • None no insider bought on the open market
  • $991K sold by 9 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Brent Neidig Chief Commercial Officer
    Sale
    $97K 5,002 shares at $19.45 100% of stake
    Traded Jun 16 Filed Jun 18
    ↗
  2. Brent Neidig Chief Commercial Officer
    Sale
    $50K 2,511 shares at $20.10 33% of stake
    Traded Jun 12–15 Filed Jun 16
    ↗
  3. Paul A. Jones Chief People Officer
    Sale
    $103K 5,561 shares at $18.50 100% of stake
    Traded Jun 8 Filed Jun 8
    ↗
  4. John Turman Fleming Director
    Sale
    $44K 2,450 shares at $17.93 37% of stake
    Traded Jun 1 Filed Jun 1
    ↗
  5. Paul A. Jones Chief People Officer
    Sale
    $129K 6,813 shares at $18.95 55% of stake
    Traded May 28 Filed May 29
    ↗
  6. G Doug Iiekking CFO
    Sale
    $101K 5,360 shares at $18.75 100% of stake
    Traded May 27 Filed May 28
    ↗
  7. Gilbert A Fuller Director
    Sale
    $20K 1,057 shares at $18.66 100% of stake
    Traded May 22 Filed May 26
    ↗
  8. Joshua Foukas Chief Legal Officer
    Sale
    $75K 3,791 shares at $19.82 100% of stake
    Traded May 7 Filed May 8
    ↗
  9. Gilbert A Fuller Director
    Sale
    $18K 1,058 shares at $17.00 100% of stake
    Traded Mar 20 Filed Mar 20
    ↗
  10. Peter Benedict Chief Information Officer
    Sale
    $88K 4,553 shares at $19.38 100% of stake
    Traded Mar 3 Filed Mar 3
    ↗
  11. Joshua Foukas Chief Legal Officer
    Sale
    $95K 4,461 shares at $21.35 100% of stake
    Traded Feb 20 Filed Feb 23
    ↗
  12. Peter Benedict Chief Information Officer
    Sale
    $56K 2,673 shares at $20.95 100% of stake
    Traded Dec 10, 2025 Filed Dec 11, 2025
    ↗
  13. David Mulham Mulham Chief Sales Officer
    Sale
    $18K 873 shares at $21.00 9.4% of stake
    Traded Dec 10, 2025 Filed Dec 11, 2025
    ↗
  14. Frederic J Winssinger Director
    Sale
    $38K 2,000 shares at $19.21 25% of stake
    Traded Nov 10, 2025 Filed Nov 10, 2025
    ↗
  15. Gilbert A Fuller Director
    Sale
    $23K 1,057 shares at $21.48 100% of stake
    Traded Nov 3, 2025 Filed Nov 4, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 59 option exercises and 43 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 9 shown.

Filed Form Detail Links
8-K 1.01,2.03,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
DEF 14A Filing Doc
SCHEDULE 13D/A — Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023
Revenue $921.01M
Gross profit $744.32M
Gross margin * 80.8%
Net income $63.79M
Net margin * 6.9%

Balance sheet

Metric FY2023
Total current assets $417.75M
Total non-current assets * $215.01M
Total assets $632.76M
Total current liabilities $118.84M
Total non-current liabilities * $16.71M
Total equity $497.2M

Cash flow

Metric FY2023
Cash from operations $70.64M
Cash from investing -$11.98M
Cash from financing -$14.24M
Net change in cash $41.93M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.